Old Web
English
Sign In
Acemap
>
Paper
>
Prediction of binding of FDA approved drug Ledipasvir to SARS-CoV2 mutants: an in silico study
Prediction of binding of FDA approved drug Ledipasvir to SARS-CoV2 mutants: an in silico study
2021
Sheemona Chowdhary
Deepak Kumar
Rajasri Bhattacharyya
Dibyajyoti Banerjee
Keywords:
Mutant
Ledipasvir
Virology
Approved drug
In silico
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]